Summary of potential priority actions for CMWG
Download
Report
Transcript Summary of potential priority actions for CMWG
Summary of potential
priority actions for
CMWG
Case Management Working
Group Meeting 8-9 July 2009
Introduction
CMWG’s role is to coordinate partners for
achieving access to treatment
Meeting needs to review TORs to clarify role and
avoid duplication
RBM Board wants a strategy on resistance
containment
CMWG is asked to address how to strengthen
implementation to increase access. Countries
need more detailed operational plans.
Activities to support RBM access targets - 549
days to do it…
Expected Outcomes
Reviewed and revised TORs of CMWG
Agreement on composition
Members
Co-chairs
Secretariat
Agreement on modus operandi – eg creation of
Task Forces (ongoing or time-limited) to achieve
certain products
List of priority actions to completed by:
November
2009
December 2010
Malaria Diagnosis
Goal is to have all treatment based on parasitological
diagnosis
Still much to do to achieve this goal
Approach should include complementary microscopy and RDT
strategy
Approach needs to address context of changing transmission
Areas for CMWG action:
Help to prioritise implementation approaches
Consider diagnosis of multiple diseases
Incentives for using diagnostics in private sector
Consideration of subsidised RDTs in AMFm – may be post2010?
Consider role of pharmaceutical companies in encouraging RDT
use in private sector
Support more attention to user and patient perceptions
Malaria Diagnosis: areas for
CMWG Action (2)
Tracking feasibility of community level RDT use
Include diagnosis as an epidemiological tool as well
as a case management tool
(fits best in this WG even if it goes beyond case
management)
this to include use of diagnostic data to track progress,
discussions on Active Case Detection, infection versus case
detection
Develop
a framework for scaling up diagnosis
Outline a package of what is needed for good
diagnosis to advise GFATM TRP what to look for
(include training, supervision etc
Malaria treatment – policy and
practice
Use partners’ communication capacity to support
use of WHO publications (Case Management
Operational Manual and Treatment Guidelines
Provide
feedback on the CMOM
Support development of tools to measure quality
of case management to show if there is progress
Support system to track drug availability
Outline a package to guide countries and TRPs
on what is acceptable in GFATM proposals
Preventing and containing drug
resistance
Plan more broadly for policy intervention that can delay
or contain resistance
Consider MDA, MSAT, deployment of new drugs.
Consider what to do when there is a choice of drugs –
sequential, mosaic etc
Gain consensus on strategy components
Outline response scenarios for different regions
Link actions such as banning monotherapy with
operational context – ensuring reliable access to ACTs
Advocate strongly for more efficacy monitoring
Make it a requirement in GFATM proposals, but also follow up in
performance monitoring
Facility-based Case Management
Encourage joint work with child health
Identify cross-cutting operational issues
between malaria and IMCI including
resource mobilisation
Community-based case
management
Support more consideration of links between public
health system and community systems
Continue and communicate mapping of initiatives on
community case management – include research and
experiential evidence
Review scaleability of primary health care approaches
Advocate support for multiple models led by countries
and assessed for effectiveness
Highlight interim as well as final targets to assess
progress
Conclusions – potential Task Forces
Scaling up parasitological diagnosis
Access, delivery systems, quality of
services
Quality and safety of drugs and
diagnostics
Strategic options for managing drug
resistance